InvestorsObserver
Sign Up Login

PBIO Pressure Biosciences

$0.24 $0.00 (-0.42%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

PBIO Stock Analysis Overview

What this means: Pressure Biosciences (PBIO) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives PBIO a rank of 8. Our methodology considers analysis of the company's financial situation and how it has traded recently. PBIO rank of 8 means that it ranks below 92% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

PBIO Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

PBIO Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

PBIO Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

PBIO Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

PBIO Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

PBIO Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

PBIO Stock Analysis Overview

What this means: Pressure Biosciences (PBIO) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives PBIO a rank of 8. Our methodology considers analysis of the company's financial situation and how it has traded recently. PBIO rank of 8 means that it ranks below 92% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full PBIO report

PBIO Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

PBIO Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

PBIO Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

PBIO Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

PBIO Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

PBIO Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Pressure Biosciences (PBIO) Analyst Forecast

PBIO Price, Volume, Earnings, and Dividend Date

  • Last Price $0.24
  • Previous Close $0.24
  • Change $0.00
  • Open $0.24
  • Volume 19,700
  • Avg. Volume (100-day) 76,286
  • Market Cap 5,192,617
  • Days Range 0.2002 - 0.24
  • 52-week Range 0.14 - 1
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date —
  • Sector Healthcare
  • Industry Medical Devices
  • Avg. Analyst Rec. Premium
  • Beta -1.568
  • PEG Ratio —

Pressure Biosciences (PBIO) Company Description

Pressure BioSciences Inc is engaged in the healthcare division. It focuses on solving the problems inherent in biological sample preparation. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kit, MicroTubes, HUB High-Pressure Generators and Accessories, RF1700 Mini Ultra-High Pressure Pump, High-Pressure Cell Disruptors from Constant Systems, and SHREDDER Tubes, Service Contracts, and others.

Pressure Biosciences (PBIO) Stock Chart

View Interactive PBIO chart

My Watchlists

Top Stocks in Medical Devices